Accéder au contenu
Merck

Auxin-mediated protein depletion for metabolic engineering in terpene-producing yeast.

Nature communications (2021-02-18)
Zeyu Lu, Bingyin Peng, Birgitta E Ebert, Geoff Dumsday, Claudia E Vickers
RÉSUMÉ

In metabolic engineering, loss-of-function experiments are used to understand and optimise metabolism. A conditional gene inactivation tool is required when gene deletion is lethal or detrimental to growth. Here, we exploit auxin-inducible protein degradation as a metabolic engineering approach in yeast. We demonstrate its effectiveness using terpenoid production. First, we target an essential prenyl-pyrophosphate metabolism protein, farnesyl pyrophosphate synthase (Erg20p). Degradation successfully redirects metabolic flux toward monoterpene (C10) production. Second, depleting hexokinase-2, a key protein in glucose signalling transduction, lifts glucose repression and boosts production of sesquiterpene (C15) nerolidol to 3.5 g L-1 in flask cultivation. Third, depleting acetyl-CoA carboxylase (Acc1p), another essential protein, delivers growth arrest without diminishing production capacity in nerolidol-producing yeast, providing a strategy to decouple growth and production. These studies demonstrate auxin-mediated protein degradation as an advanced tool for metabolic engineering. It also has potential for broader metabolic perturbation studies to better understand metabolism.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Géraniol, 98%
Sigma-Aldrich
(R)-(+)-Limonène, ≥93%
Sigma-Aldrich
trans,trans-Farnesol, 96%
Sigma-Aldrich
Geranylgeraniol, ≥85% (GC)